New approach in treatment of cardiac decompensation in U.S.S.R.
D000251:Adenosine Triphosphatases / Q000502:physiology; D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000596:Amino Acids / Q000096:biosynthesis; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D002301:Cardiac Glycosides / Q000627:therapeutic use*; D004071:Digitalis Glycosides / Q000009:adverse effects; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006352:Heart Ventricles; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006984:Hypertrophy; D008715:Methionine / Q000627:therapeutic use; D009218:Myosins / Q000502:physiology; D009696:Nucleic Acids / Q000096:biosynthesis; D009963:Orotic Acid / Q000627:therapeutic use*; D010205:Pantothenic Acid / Q000627:therapeutic use; D014176:Protein Biosynthesis; D011498:Protein Precursors / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000627:therapeutic use; D014586:USSR; D014805:Vitamin B 12 / Q000627:therapeutic use*
D000596:Amino Acids; D002301:Cardiac Glycosides; D004071:Digitalis Glycosides; D004232:Diuretics; D009696:Nucleic Acids; D011498:Protein Precursors; D013328:Strophanthins; D010205:Pantothenic Acid; D009963:Orotic Acid; D000255:Adenosine Triphosphate; D008715:Methionine; D000251:Adenosine Triphosphatases; D009218:Myosins; D014805:Vitamin B 12